Breaking News Instant updates and real-time market news.

AVRO

Avrobio

$38.85

3.2 (8.98%)

08:06
08/09/18
08/09
08:06
08/09/18
08:06

AvroBio reports Q2 EPS ($2.98), consensus (47c)

AvroBio said the increase in net loss for the year was due to increased research and development expenses, as well as an increase in general and administrative expenses primarily related to investments in the company's infrastructure in preparation for becoming a publicly traded company. AvroBio ended the quarter with $155M in cash. Based on its current operating plan, the company expects its cash and cash equivalents will enable it to fund its operating expenses and capital expenditure requirements into 2020. It said, "2018 has been a very productive year thus far for AVROBIO. We successfully completed a Series B financing and a successful initial public offering which positions us well to achieve our mission of advancing our pipeline of gene therapies to cure rare diseases in a single dose. Our main focus is on the patients, and I am pleased with the progress we have made with our lead program, AVR-RD-01 in Fabry disease. In June, we completed the enrollment of the first patient in our Phase 2 clinical trial, and even more recently, the third patient was enrolled in our ongoing investigator-sponsored Phase 1 clinical trial."

  • 14

    Aug

AVRO Avrobio
$38.85

3.2 (8.98%)

07/16/18
WEDB
07/16/18
INITIATION
Target $38
WEDB
Outperform
AvroBio initiated with an Outperform at Wedbush
Wedbush analyst David Nierengarten started AvroBio with an Outperform rating and $38 price target as he believes the shares could have significant upside given that its gene therapy platform is developing potentially curative therapies for rare lysosomal storage diseases that are poorly controlled on current treatments.
07/16/18
MSCO
07/16/18
INITIATION
Target $37
MSCO
Overweight
AvroBio initiated with an Overweight at Morgan Stanley
Morgan Stanley analyst David Lebowitz initiated AvroBio (AVRO) with an Overweight rating and $37 price target, noting that its a unique gene therapy company that has human clinical data for one of its programs at the time of its initial public offering. He points to Novartis' (NVS) recent acquisition of AveXis for $8.7B, or an 88% premium, as an illustration of the substantial interest in and valuation premium put into many names in the gene therapy space.
07/16/18
COWN
07/16/18
INITIATION
COWN
Outperform
AvroBio initiated with an Outperform at Cowen
Cowen analyst Ritu Baral initiated AvroBio with an Outperform rating citing its four programs that have been generated from its lentiviral gene therapy platform for lysomal storage diseases. The analyst expects the company to create long-term value with its gene therapy programs.
07/16/18
WELS
07/16/18
INITIATION
Target $40
WELS
Outperform
AvroBio initiated with an Outperform at Wells Fargo
Wells Fargo analyst Jim Birchenough started AvroBio with an Outperform rating and $40 price target based on what he views as a differentiated capability in applying lentiviral-based gene therapy, a proven platform with curative potential, to lysosomal storage diseases, proof-of-mechanism afforded by existing LSD treatment approaches including enzyme replacement therapy and allogeneic hematopoietic stem cell transplant, encouraging initial phase 1 data in Fabry disease demonstrating rapid, robust, and sustained enzyme expression, and a leverageable platform that extends to multiple LSDs with established markets and multibillion dollar opportunities.

TODAY'S FREE FLY STORIES

09:30
11/15/18
11/15
09:30
11/15/18
09:30
General news
U.S. Retail sales undershot estimates via downward revisions »

U.S. Retail sales…

CPB

Campbell Soup

$39.16

-0.1 (-0.25%)

09:29
11/15/18
11/15
09:29
11/15/18
09:29
Hot Stocks
Campbell Soup 'largely agrees' with views outlined by Glass Lewis »

Campbell Soup Company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

DEI

Douglas Emmett

$35.66

-0.26 (-0.72%)

09:29
11/15/18
11/15
09:29
11/15/18
09:29
Upgrade
Douglas Emmett rating change  »

Sandler upgrades Douglas…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 28

    Nov

ANET

Arista Networks

$229.27

-7.23 (-3.06%)

, CSCO

Cisco

$44.35

-0.78 (-1.73%)

09:28
11/15/18
11/15
09:28
11/15/18
09:28
Conference/Events
Piper Jaffray tech/IT hardware analyst to hold analyst/industry conference call »

Technology/IT Hardware…

ANET

Arista Networks

$229.27

-7.23 (-3.06%)

CSCO

Cisco

$44.35

-0.78 (-1.73%)

JNPR

Juniper

$28.14

-0.15 (-0.53%)

NTCT

NetScout

$25.30

-0.7 (-2.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 03

    Dec

  • 05

    Dec

  • 05

    Dec

  • 10

    Jan

KMG

KMG Chemicals

$75.99

-0.065 (-0.09%)

, CCMP

Cabot Microelectronics

$101.60

-0.62 (-0.61%)

09:27
11/15/18
11/15
09:27
11/15/18
09:27
Hot Stocks
KMG Chemicals shareholders approve merger with Cabot Microelectronics »

In a regulatory filing,…

KMG

KMG Chemicals

$75.99

-0.065 (-0.09%)

CCMP

Cabot Microelectronics

$101.60

-0.62 (-0.61%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 28

    Nov

  • 11

    Dec

  • 12

    Dec

EYE

National Vision

$41.79

0.72 (1.75%)

09:27
11/15/18
11/15
09:27
11/15/18
09:27
Syndicate
National Vision 12.5M share Spot Secondary priced at $40.50 »

Goldman Sachs and Citi…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:25
11/15/18
11/15
09:25
11/15/18
09:25
General news
FX Action: USD-JPY »

FX Action: USD-JPY has…

09:25
11/15/18
11/15
09:25
11/15/18
09:25
General news
Other Fedspeakers on tap include VC of Supervision Quarles »

Other Fedspeakers on tap…

SSNC

SS&C

$46.71

-0.72 (-1.52%)

09:25
11/15/18
11/15
09:25
11/15/18
09:25
Conference/Events
SS&C to host analyst day »

Analyst Day to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 26

    Nov

09:25
11/15/18
11/15
09:25
11/15/18
09:25
Conference/Events
UBS leisure/lodging analyst to hold an analyst/industry conference call »

Leisure, Gaming &…

09:25
11/15/18
11/15
09:25
11/15/18
09:25
Conference/Events
Bernstein transportation analysts to hold an analyst/industry conference call »

European Transportation…

JD

JD.com

$22.75

0.37 (1.65%)

09:24
11/15/18
11/15
09:24
11/15/18
09:24
Recommendations
JD.com analyst commentary  »

JD.com price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

JCP

J.C. Penney

$1.23

-0.05 (-3.91%)

09:23
11/15/18
11/15
09:23
11/15/18
09:23
Hot Stocks
Breaking Hot Stocks news story on J.C. Penney »

J.C. Penney sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

SSTI

ShotSpotter

$31.46

-5.695 (-15.33%)

09:21
11/15/18
11/15
09:21
11/15/18
09:21
Recommendations
ShotSpotter analyst commentary  »

ShotSpotter selloff…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OBLN

Obalon Therapeutics

$2.07

0.02 (0.98%)

09:20
11/15/18
11/15
09:20
11/15/18
09:20
Hot Stocks
Obalon Therapeutics announces data from Obalon Balloon System at Obesity Week »

Obalon Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

KMG

KMG Chemicals

$75.99

-0.065 (-0.09%)

09:20
11/15/18
11/15
09:20
11/15/18
09:20
Hot Stocks
Breaking Hot Stocks news story on KMG Chemicals »

KMG Chemicals trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TYL

Tyler Technologies

$187.30

-0.28 (-0.15%)

09:20
11/15/18
11/15
09:20
11/15/18
09:20
Hot Stocks
Tyler Technologies says Multnomah County, Oregon goes live with Orion solution »

Tyler Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 20

    Nov

  • 27

    Nov

  • 28

    Nov

  • 29

    Nov

  • 11

    Dec

BSX

Boston Scientific

$36.21

-0.46 (-1.25%)

09:20
11/15/18
11/15
09:20
11/15/18
09:20
Recommendations
Boston Scientific analyst commentary  »

Boston Scientific price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 27

    Nov

09:20
11/15/18
11/15
09:20
11/15/18
09:20
General news
U.S. November Empire State index rose 2.2 points to 23.3 »

U.S. November Empire…

SYNC

Synacor

$1.77

0.04 (2.31%)

09:18
11/15/18
11/15
09:18
11/15/18
09:18
Hot Stocks
Synacor says over 80 new customers deployed Zimbra in Q3 »

Synacor announced its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

TST

TheStreet

$1.97

0.17 (9.44%)

09:18
11/15/18
11/15
09:18
11/15/18
09:18
Recommendations
TheStreet analyst commentary  »

TheStreet deferred…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRNO

Terreno Realty

$38.86

0.01 (0.03%)

09:18
11/15/18
11/15
09:18
11/15/18
09:18
Hot Stocks
Terreno Realty acquires property in Santa Fe Springs for $6.4M »

Terreno Realty acquired…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

09:18
11/15/18
11/15
09:18
11/15/18
09:18
Options
Overnight activity included 416 trades in SPX and 42 trades in VIX »

416 trades were executed…

SPX

S&P 500

$0.00

(0.00%)

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DSX

Diana Shipping

$3.21

-0.08 (-2.43%)

09:16
11/15/18
11/15
09:16
11/15/18
09:16
Hot Stocks
Diana Shipping announces time charter contract with Hudson Shipping Lines »

Diana Shipping announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

HE

Hawaiian Electric

$37.80

0.12 (0.32%)

09:16
11/15/18
11/15
09:16
11/15/18
09:16
Downgrade
Hawaiian Electric rating change  »

Hawaiian Electric…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.